All News

The recall comes in the wake of discovering cracks in the vials' necks that could keep the drug from remaining sterile.

It will be out of commission for system maintenance on Aug. 10.

Customers can join its rewards club at a one-time fee of $10.

This approval spares health professionals from having to start a patient on a single medication, according to Novartis.

Clean and sober for eight years now, he candidly shares details about his life and his journey to recovery.

The accuracy of self-monitoring kits for hypertension and diabetes can vary greatly.

The physicians could face a maximum of five years in prison and $250,000 fines.

A newspaper in the Cincinnati area ran an article listing three reasons why pharmacists are respected more than politicians and even the clergy.

The Food and Drug Administration announced stricter limits on conflicts of interests for members of its advisory committees.

The National Multiple Sclerosis Society issued a position statement about the latest development.

Rollouts expected at the National Association of Chain Drug Stores' conference in San Diego this month.

An exclusive Drug Topics survey asked, "With the presidential election coming up, whom do you plan to vote for?"

Three companies are offering resources to help pharmacists with compounding.

Rite Aid drugstores will offer patients a free Oral Care Guide and an Oral Care Tip Book.

Erythropoiesis stimulating agents will bear stricter labeling.

One lot was found to contain a potentially harmful, undeclared ingredient.

Move comes as part of a broader effort to encourage the adoption of health information technology.

A court had granted Medicaid providers a preliminary injunction against the proposed cuts.

Pharmacies that violate this rule could be fined up to $1,000.

The generic version will carry the same warnings as Depakote.

Customers in the program will get a 10% discount coupon after every five prescriptions filled.

Newsletter addresses everything from clinical information on diabetes to recipes for diabetics.

FDA also issued a new recommendation for MS patients who have had treatment with mitoxantrone.

Contributing to the errors were wider use of painkillers and drug overdoses.

Many ongoing implementation problems remain for this drug benefit program.

Vancomycin and Zyvox are the two antibiotics that physicians use most frequently to treat MRSA infections.

About 400 drugs are available at the low price.

The records show that there have been 10 new deaths since September 2007.